A trial looking at adaptive therapy with carboplatin chemotherapy for advanced ovarian cancer (ACTOv)

This trial is looking at a new way of giving carboplatin chemotherapy called adaptive therapy. It is comparing this to having standard carboplatin chemotherapy for ovarian cancer.

It is for women whose cancer has come back after platinum chemotherapy. And who have one of the following types of cancer:

• epithelial ovarian cancer

• fallopian tube cancer

• primary peritoneal cancer

These cancers are treated in the same way, so when we use the term ovarian cancer in this summary, we are referring to all three.